← SynDRA
PAVINETANT
SynDRA canonical compound SYN0038250 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | TACR3 |
| Mechanism of action | neurokinin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- TACR3 ANTAGONIST
- Neurokinin 3 receptor antagonist
- neurokinin receptor antagonist
- TACR3 MODULATOR
Cross-references
Synonyms
- Azd-2624
- AZD-4901
- AZD2624
- AZ-12472520
- AZ12472520
- AZ124752520
- AZ4901
- AZD4901
- MLE-4901
- MLE4901
- AZD-2624
- UNII-3U471ZVC5K
- 3U471ZVC5K
- pavinetantum
- Pavinetant [USAN]
- SCHEMBL3587478
- GTPL5775
- CHEMBL3545233
- CHEBI:140478
- QYTBBBAHNIWFOD-NRFANRHFSA-N
- BDBM50180193
- AKOS032946112
- DB11692
- CS-7979
- 4-Quinolinecarboxamide, 3-((methylsulfonyl)amino)-2-phenyl-N-((1S)-1-phenylpropyl)-
- HY-14432
- KB-74807
- 3-methanesulfonamido-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide
- 3-[(methanesulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide
- AZD 2624
- Azd 4901
- PAVINETANT [INN]
- AZD 4901 [WHO-DD]
- RefChem:858744
- AZD 2624 [WHO-DD]
- DTXCID601345170
- Pavinetant [WHO-DD]
- Pavinetant (USAN/INN)
- orb1706961
Look up PAVINETANT in the interactive SynDRA portal →